Literature DB >> 18039105

Body traffic: ecology, genetics, and immunity in inflammatory bowel disease.

Jonathan Braun1, Bo Wei.   

Abstract

The abundant bacteria and other microbial residents of the human intestine play important roles in nutrient absorption, energy metabolism, and defense against microbial pathogens. The mutually beneficial relationship of host and commensal microbiota represents an ancient and major coevolution in composition and mutual regulation of the human mucosa and the resident microbial community. Inflammatory bowel disease (IBD) is a set of chronic, relapsing inflammatory intestinal diseases in which rules of normal host-microbial interaction have been violated. This review considers the components of this host-microbial mutualism and the ways in which it is undermined by pathogenic microbial traits and by host immune and epithelial functions that confer to them susceptibility in patients with IBD. Recent advances in understanding the genetics of IBD and the immunology of host-microbial interaction are opening new strategies for treatments that target host susceptibility, candidate microbial pathogens, and intestinal ecology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18039105     DOI: 10.1146/annurev.pathol.1.110304.100128

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  17 in total

1.  Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease.

Authors:  Akira Andoh; Hiroyuki Kuzuoka; Tomoyuki Tsujikawa; Shiro Nakamura; Fumihito Hirai; Yasuo Suzuki; Toshiyuki Matsui; Yoshihide Fujiyama; Takayuki Matsumoto
Journal:  J Gastroenterol       Date:  2012-05-11       Impact factor: 7.527

2.  Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis.

Authors:  Akira Andoh; Hirotsugu Imaeda; Tomoki Aomatsu; Osamu Inatomi; Shigeki Bamba; Masaya Sasaki; Yasuharu Saito; Tomoyuki Tsujikawa; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2011-01-21       Impact factor: 7.527

3.  RNA Identification of PRIME Cells Predicting Rheumatoid Arthritis Flares.

Authors:  Dana E Orange; Vicky Yao; Kirsty Sawicka; John Fak; Mayu O Frank; Salina Parveen; Nathalie E Blachere; Caryn Hale; Fan Zhang; Soumya Raychaudhuri; Olga G Troyanskaya; Robert B Darnell
Journal:  N Engl J Med       Date:  2020-07-16       Impact factor: 91.245

4.  Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model.

Authors:  Qin Qi; Ya-Nan Liu; Xiao-Ming Jin; Lin-Shuang Zhang; Cun Wang; Chun-Hui Bao; Hui-Rong Liu; Huan-Gan Wu; Xiao-Mei Wang
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 5.  Genetic risks and familial associations of small bowel carcinoma.

Authors:  Santosh Shenoy
Journal:  World J Gastrointest Oncol       Date:  2016-06-15

Review 6.  Pro-resolving mediators in the regulation of periodontal disease.

Authors:  Thomas E Van Dyke
Journal:  Mol Aspects Med       Date:  2017-05-18

7.  Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes.

Authors:  Bruno S Herrera; Hatice Hasturk; Alpdogan Kantarci; Marcelo O Freire; Olivia Nguyen; Shevali Kansal; Thomas E Van Dyke
Journal:  Infect Immun       Date:  2014-12-08       Impact factor: 3.441

8.  Dietary phenethylisothiocyanate attenuates bowel inflammation in mice.

Authors:  Moul Dey; Peter Kuhn; David Ribnicky; Vummidigiridhar Premkumar; Kenneth Reuhl; Ilya Raskin
Journal:  BMC Chem Biol       Date:  2010-04-27

9.  Colitis immunoregulation by CD8+ T cell requires T cell cytotoxicity and B cell peptide antigen presentation.

Authors:  Michael McPherson; Bo Wei; Olga Turovskaya; Daisuke Fujiwara; Sarah Brewer; Jonathan Braun
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-07-10       Impact factor: 4.052

Review 10.  The epidemiology and pathogenesis of neoplasia in the small intestine.

Authors:  David Schottenfeld; Jennifer L Beebe-Dimmer; Fawn D Vigneau
Journal:  Ann Epidemiol       Date:  2009-01       Impact factor: 3.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.